EZH2 and neoplasm: A confounding factor, however, is that the expression of EZH2 occurs in both tumor cells and in tumor-associated innate and adaptive immune cells (e.g., tumor-infiltrating neutrophils (TINs) and lymphocytes (TILs), respectively) [7].